opc1
opc1: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | Phase 1 |
Clinical Trials (1)
Delivery of Oligodendrocyte Progenitor Cells for Spinal Cord Injury: Evaluation of a Novel Device (DOSED)
Frequently asked questions
Who is developing opc1?
opc1 is being developed by Lineage Cell Therapeutics, Inc..
How many clinical trials involve opc1?
BioSniper tracks 1 clinical trial involving opc1.
Get deeper analysis on opc1
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis